Trifluoroacetic acid → 5-(5-(3-Hydroxy-3-methylbut-1-ynyl)-4-(piperidin-4-ylmethylamino)pyridin-2-ylamino)pyrazine-2-carbonitrile
反応式
C(O)(C(F)(F)F)=O.[C:8]([C:10]1[N:11]=[CH:12][C:13]([NH:16][C:17]2[CH:22]=[C:21]([NH:23][CH2:24][CH:25]3[CH2:30][CH2:29][N:28](C(OC(C)(C)C)=O)[CH2:27][CH2:26]3)[C:20]([C:38]#[C:39][C:40]([OH:43])([CH3:42])[CH3:41])=[CH:19][N:18]=2)=[N:14][CH:15]=1)#[N:9]>ClCCl>[OH:43][C:40]([CH3:42])([CH3:41])[C:39]#[C:38][C:20]1[C:21]([NH:23][CH2:24][CH:25]2[CH2:26][CH2:27][NH:28][CH2:29][CH2:30]2)=[CH:22][C:17]([NH:16][C:13]2[N:14]=[CH:15][C:10]([C:8]#[N:9])=[N:11][CH:12]=2)=[N:18][CH:19]=1参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
TFA (0.2 mL) was added at room temperature to a solution of tert-butyl 4-((2-(5-cyanopyrazin-2-ylamino)-5-(3-hydroxy-3-methylbut-1-ynyl)pyridin-4-ylamino)methyl)piperidine-1-carboxylate (0.020 g, 0.041 mmol) dissolved in dichloromethane (2 mL). The reaction mixture was stirred for 20 min. Solvent was removed in vacuo and the crude mixture was purified by ion exchange on SCX-II acidic resin (500 mg), eluting with methanol then 2M ammonia-methanol. The basic fractions were combined and solvent was removed in vacuo. The crude product was purified by preparative thin layer chromatography, eluting with methanol/dichloromethane (1/19), to give the title compound as a yellow solid (0.008 g, 50%).
後処理
- customSolvent was removed in vacuo
- customthe crude mixture was purified by ion exchange on SCX-II acidic resin (500 mg)
- washeluting with methanol
- customsolvent was removed in vacuo
- customThe crude product was purified by preparative thin layer chromatography
- washeluting with methanol/dichloromethane (1/19)
出典と根拠
- ORDレコード
- ord-129bc5d8ac80425eb5e31c0cf4c34ff7
- 出典データセット
- uspto-grants-2011_11
- 特許番号
- US08058045B2
反応ノート
読み込み中…